Search by Drug Name or NDC

    NDC 00093-3727-55 diclofenac epolamine 0.013 g/1 Details

    diclofenac epolamine 0.013 g/1

    diclofenac epolamine is a TOPICAL SYSTEM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA Inc.. The primary component is DICLOFENAC EPOLAMINE.

    Product Information

    NDC 00093-3727
    Product ID 0093-3727_0b712273-bf2e-52ca-e063-6294a90aa935
    Associated GPIs 90210030205920
    GCN Sequence Number 062176
    GCN Sequence Number Description diclofenac epolamine PATCH TD12 1.3 % TRANSDERM
    HIC3 Q5E
    HIC3 Description TOPICAL ANTI-INFLAMMATORY, NSAIDS
    GCN 97958
    HICL Sequence Number 020420
    HICL Sequence Number Description DICLOFENAC EPOLAMINE
    Brand/Generic Generic
    Proprietary Name diclofenac epolamine
    Proprietary Name Suffix n/a
    Non-Proprietary Name diclofenac epolamine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SYSTEM
    Route TOPICAL
    Active Ingredient Strength 0.013
    Active Ingredient Units g/1
    Substance Name DICLOFENAC EPOLAMINE
    Labeler Name Teva Pharmaceuticals USA Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021234
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-3727-55 (00093372755)

    NDC Package Code 0093-3727-55
    Billing NDC 00093372755
    Package 6 POUCH in 1 CARTON (0093-3727-55) / 5 SYSTEM in 1 POUCH (0093-3727-50)
    Marketing Start Date 2020-05-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 5.26535
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DICLOFENAC EPOLAMINE 1.3% PTCH
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 6
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis